δ-Opioid receptor agonists produce antinociception and [35S]GTPγS binding in μ receptor knockout mice

European Journal of Pharmacology

Volumn 388, Issue 3, 2000, Pages 241-248

  Hosohata, Yoshiaki ^a   Vanderah, Todd W ^a   Burkey, Thomas H ^a   Ossipov, Michael H ^a   Kovelowski, Carl J ^a   Sora, Ichiro ^c   Uhl, George R ^c,d   Zhang, Xiaoyan ^e   Rice, Kenner C ^e   Roeske, William R ^a   Hruby, Victor J ^b   Yamamura, Henry I ^a   Lai, Josephine ^a   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b University of Arizona   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Opioid receptor; Opioid receptor; Opioid receptor knockout mice; Antinociception; G protein; Opioid drug

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN[2 DEXTRO ALANINE 4 GLUTAMIC ACID]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE 4 (4 CHLOROPHENYLALANINE)]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG RESPONSE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; BRAIN; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MEMBRANES; MICE; MICE, KNOCKOUT; OLIGOPEPTIDES; PAIN MEASUREMENT; PIPERAZINES; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SPINAL CORD;

EID: 0033962799     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00897-3     Document Type: Article

References (19)

1. Bilsky E.J., Bernstein R.N., Hruby V.J., Rothman R.B., Lai J., Porreca F. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptors in vivo. J. Pharmacol. Exp. Ther. 277:1996;491-501.
2. Clark M.J., Emmerson P.J., Mansour A., Akil H., Woods J.H., Portoghese P.S., Remmers A.E., Medzihradsky F. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. J. Pharmacol. Exp. Ther. 283:1997;501-510.
3. Heyman J.S., Mulvaney S.A., Mosberg H.I., Porreca F. Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res. 420:1987;100-108.
4. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
5. Jiang Q., Mosberg H.I., Porreca F. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J. Pharmacol. Exp. Ther. 254:1990;683-689.
6. Knapp R.J., Santoro G., DeLeon I.A., Lee K.B., Edsall S.A., Waite S., Malatynska E., Varga E., Calderon S.N., Rice K.C., Rothman R.B., Porreca F., Roeske W.R., Yamamura H.I. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors. J. Pharmacol. Exp. Ther. 277:1996;1284-1291.
7. Kramer T.H., Davis P., Hruby V.J., Burks T.F., Porreca F. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands. J. Pharmacol. Exp. Ther. 266:1993;577-584.
8. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dollé P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 383:1996;819-823.
9. Matthes H.W.D., Smadja C., Valverde O., Vonesch J.-L., Foutz A.S., Boudinot E., Denavit-Saubié M., Severini C., Negri L., Roques B.P., Maldonado R., Kieffer B.L. Activity of the δ-opioid receptor is partially reduced, whereas activity of the κ-receptor is maintained in mice lacking the μ-receptor. J. Neurosci. 18:1998;7285-7295.
10. 2]deltorphin II in mice: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258:1991;583-587.
11. 5]enkephalin in the mouse. J. Pharmacol. Exp. Ther. 241:1987;393-400.
12. Shah S., Davis T., Yoburn B.C. The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesia. Life Sci. 55:1994;1451-1458.
13. 5]enkephalin-induced analgesia. Eur. J. Pharmacol. 324:1997a;R1-R2.
14. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., Uhl G.R. Opiate receptor knockout mice define μ-receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U.S.A. 94:1997b;1544-1549.
15. Standifer K.M., Chien C.C., Wahlestedt C., Brown G.P., Pasternak G.W. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron. 12:1997;805-810.
16. Tallarida R.J., Murray R.B. Manual of Pharmacologic Calculations with Computer Programs. 1987;Springer, New York, NY.
17. Tseng L.F., Collins K.A., Kampine J.P. Antisense oligodeoxynucleotide to a δ-opioid receptor selectively blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid agonists in the mouse. Eur. J. Pharmacol. 258:1994;R1-R3.
18. Vaught J.L., Rothman R.B., Westfall T.C. Mu and delta receptors: their role in analgesia and in the differential effects of opioid peptides on analgesia. Life Sci. 30:1982;1443-1455.
19. Welch S.P., Stevens D.L. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J. Pharmacol. Exp. Ther. 262:1992;10-18.